Obesity, Inflammation, and Periodontal Disease
暂无分享,去创建一个
S. Willich | T. Pischon | J. Bernimoulin | N. Pischon | B. Kleber | N. Heng
[1] Nimesh Mody,et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes , 2005, Nature.
[2] F. Peale,et al. FIZZ1, a novel cysteine‐rich secreted protein associated with pulmonary inflammation, defines a new gene family , 2000, The EMBO journal.
[3] J. Beck,et al. Systemic Effects of Periodontitis: Epidemiology of Periodontal Disease and Cardiovascular Disease. , 2005, Journal of periodontology.
[4] E. Rimm,et al. Increased physical activity decreases periodontitis risk in men , 2004, European Journal of Epidemiology.
[5] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.
[6] G. Frühbeck,et al. Do resistin and resistin-like molecules also link obesity to inflammatory diseases?. , 2001, Annals of internal medicine.
[7] C. Streckfus,et al. Comparison of body composition and periodontal disease using nutritional assessment techniques: Third National Health and Nutrition Examination Survey (NHANES III). , 2003, Journal of clinical periodontology.
[8] B. Burguera,et al. Is Leptin the Link Between Fat and Bone Mass? , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] E. Borawski,et al. Increased physical activity reduces prevalence of periodontitis. , 2005, Journal of dentistry.
[10] S. Verma,et al. Resistin Promotes Endothelial Cell Activation: Further Evidence of Adipokine-Endothelial Interaction , 2003, Circulation.
[11] S. Rössner,et al. What is “obesity” – An analysis of referral letters to an obesity unit , 1998, International Journal of Obesity.
[12] Philippe Froguel,et al. Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation* , 2002, The Journal of Biological Chemistry.
[13] K. Flegal. Excess deaths associated with obesity: cause and effect , 2006, International Journal of Obesity.
[14] P. Ridker. On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. , 2002, Circulation.
[15] C. Drevon,et al. Leptin Is Expressed in and Secreted from Primary Cultures of Human Osteoblasts and Promotes Bone Mineralization , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] Y. Ichihara,et al. Associations of medical status and physical fitness with periodontal disease. , 1999, Journal of clinical periodontology.
[17] A Tremblay,et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. , 1994, The American journal of cardiology.
[18] R. Genco,et al. A Proposed Model Linking Inflammation to Obesity, Diabetes, and Periodontal Infections. , 2005, Journal of periodontology.
[19] GS Hotamisligil,et al. Molecular mechanisms of insulin resistance and the role of the adipocyte , 2000, International Journal of Obesity.
[20] R. Oppermann,et al. Overweight and obesity as risk indicators for periodontitis in adults. , 2005, Journal of periodontology.
[21] Jan J. Clark,et al. Obesity: impediment to postsurgical wound healing. , 2004, Advances in skin & wound care.
[22] Jonathan Krakoff,et al. Adiponectin and development of type 2 diabetes in the Pima Indian population , 2002, The Lancet.
[23] R. Garcia,et al. Associations Between Periodontal Disease and Systemic Disease: Evaluating the Strength of the Evidence. , 2005, Journal of periodontology.
[24] M. Matsuda,et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.
[25] H. Boeing,et al. Adiponectin and protection against type 2 diabetes mellitus , 2003, The Lancet.
[26] S. Kihara,et al. Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001, Circulation.
[27] S. Yusuf,et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study , 2005, The Lancet.
[28] McGinnis Jm,et al. Actual causes of death in the United States. , 1993 .
[29] U. Smith,et al. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. , 2001, Biochemical and biophysical research communications.
[30] Tatsuya Takeshita,et al. Determination of smoking and obesity as periodontitis risks using the classification and regression tree method. , 2005, Journal of periodontology.
[31] S. Grundy,et al. National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .
[32] S. Kihara,et al. Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell , 2002, Circulation.
[33] G. Karsenty,et al. The osteoblast: a sophisticated fibroblast under central surveillance. , 2000, Science.
[34] W. Elliott. Secular Trends in Cardiovascular Disease Risk Factors According to Body Mass Index in US Adults , 2006 .
[35] J. Greenberg. Underweight, overweight, obesity, and excess deaths. , 2005, JAMA.
[36] R. Nagai,et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. , 2004, Biochemical and biophysical research communications.
[37] J. Manson,et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.
[38] J. Kolanowski. Obesity and hypertension: from pathophysiology to treatment , 1999, International Journal of Obesity.
[39] I. Reid,et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. , 2002, The Journal of endocrinology.
[40] F. Casanueva,et al. Leptin, from fat to inflammation: old questions and new insights , 2005, FEBS letters.
[41] B. Howard,et al. Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. , 2006, The Journal of clinical endocrinology and metabolism.
[42] S. Offenbacher. Periodontal diseases: pathogenesis. , 1996, Annals of periodontology.
[43] T. Saito,et al. Relationship between Upper Body Obesity and Periodontitis , 2001, Journal of dental research.
[44] M. Gail,et al. Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial , 2005, Gynecologic oncology.
[45] G. Hotamisligil. The role of TNFalpha and TNF receptors in obesity and insulin resistance. , 1999, Journal of internal medicine.
[46] K. Flegal,et al. Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.
[47] P. Vokonas,et al. Periodontal Disease and Cardiovascular Disease. , 1996, Journal of periodontology.
[48] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[49] K. Flegal,et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. , 2005, JAMA.
[50] A. Barthel,et al. Molecular mechanisms of insulin resistance , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[51] E. Borawski,et al. Periodontitis and three health-enhancing behaviors: maintaining normal weight, engaging in recommended level of exercise, and consuming a high-quality diet. , 2005, Journal of periodontology.
[52] S. O’Rahilly,et al. Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. , 2001, Diabetes.
[53] A. Mokdad,et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.
[54] M. Lazar,et al. The hormone resistin links obesity to diabetes , 2001, Nature.
[55] Xiao Man Yang,et al. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-α in adipose tissue , 2002 .
[56] R. P. Raman. Obesity and Health Risks , 2002, Journal of the American College of Nutrition.
[57] F. Pi‐Sunyer,et al. Obesity and type 2 diabetes. , 2003, Endocrinology and metabolism clinics of North America.
[58] M. Thun,et al. Body-mass index and mortality in a prospective cohort of U.S. adults. , 1999, The New England journal of medicine.
[59] S Margetic,et al. Leptin: a review of its peripheral actions and interactions , 2002, International Journal of Obesity.
[60] M. Jensen,et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. , 1999, Endocrinology.
[61] G. Colditz,et al. The disease burden associated with overweight and obesity. , 1999, JAMA.
[62] Leonard H. Epstein,et al. Overweight, obesity, and health risk. , 2000, Archives of internal medicine.
[63] H. Krumholz,et al. The obesity paradox: body mass index and outcomes in patients with heart failure. , 2005, Archives of internal medicine.
[64] R. B. Johnson,et al. Leptin within healthy and diseased human gingiva. , 2001, Journal of periodontology.
[65] Ralph B D'Agostino,et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. , 2002, Archives of internal medicine.
[66] M. Matsuda,et al. Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin , 2005, Science.
[67] K. Kempers,et al. Obesity: prevalence and considerations in oral and maxillofacial surgery. , 2000, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[68] S. Kihara,et al. Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.
[69] G. Bray,et al. Obesity , 2008, Annals of Internal Medicine.
[70] Vilmundur Gudnason,et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.
[71] Xiao Man Yang,et al. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue. , 2002, Molecular endocrinology.
[72] Dana Dabelea,et al. The metabolic syndrome. , 2008, Endocrine reviews.
[73] L Wood,et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.
[74] D. Levy,et al. Obesity and the risk of heart failure. , 2003, The New England journal of medicine.
[75] K. Maeda. Hepatocellular injury in a patient receiving pioglitazone. , 2001, Annals of internal medicine.
[76] G. C. Kennedy,et al. The role of depot fat in the hypothalamic control of food intake in the rat , 1953, Proceedings of the Royal Society of London. Series B - Biological Sciences.
[77] J. Friedman. Leptin, leptin receptors, and the control of body weight. , 1998, Nutrition reviews.
[78] Jing Ma,et al. Inflammatory markers and the risk of coronary heart disease in men and women. , 2004, The New England journal of medicine.
[79] F. Nishimura,et al. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. , 2003, Journal of periodontology.
[80] J. Seidell,et al. Obesity, insulin resistance and diabetes — a worldwide epidemic , 2000, British Journal of Nutrition.
[81] Mohammad S Al-Zahrani,et al. Obesity and periodontal disease in young, middle-aged, and older adults. , 2003, Journal of periodontology.
[82] P. Scherer,et al. Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.
[83] P. Ridker,et al. Do atherosclerosis and type 2 diabetes share a common inflammatory basis? , 2002, European heart journal.
[84] V. Choo. WHO reassesses appropriate body-mass index for Asian populations , 2002, The Lancet.
[85] Michael Stumvoll,et al. Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.
[86] S. Koletsky. Obese spontaneously hypertensive rats--a model for study of atherosclerosis. , 1973, Experimental and molecular pathology.
[87] G. Fantuzzi,et al. IL-1 beta mediates leptin induction during inflammation. , 1998, The American journal of physiology.
[88] M. Salo,et al. Long-term physical inactivity and oral health in Finnish adults with intellectual disability , 2002, Acta odontologica Scandinavica.
[89] G. Fantuzzi,et al. IL-1β mediates leptin induction during inflammation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[90] J. Friedman. Leptin, leptin receptors and the control of body weight. , 2009, European journal of medical research.
[91] A. Wolf,et al. The medical‐care cost burden of obesity , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[92] N. Bissada,et al. Influence of obesity and hypertension on the severity of periodontitis in rats. , 1977, Oral surgery, oral medicine, and oral pathology.
[93] T. Zucker,et al. Hereditary Obesity in the Rat Associated with High Serum Fat and Cholesterol.∗ , 1962 .
[94] G A Colditz,et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. , 2001, Archives of internal medicine.
[95] T. Thomas. Leptin: a potential mediator for protective effects of fat mass on bone tissue. , 2003, Joint, bone, spine : revue du rhumatisme.
[96] E. Frongillo,et al. The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[97] M. Armstrong. Obesity as an intrinsic factor affecting wound healing. , 1998, Journal of wound care.
[98] B. Loos. Systemic Markers of Inflammation in Periodontitis. , 2005, Journal of periodontology.
[99] R. Semba. The role of vitamin A and related retinoids in immune function. , 2009, Nutrition reviews.
[100] R. Genco,et al. Periodontal disease and diabetes mellitus: a two-way relationship. , 1998, Annals of periodontology.
[101] G. Hotamisligil. The role of TNFα and TNF receptors in obesity and insulin resistance , 1999 .
[102] U. Smith,et al. Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects* , 2003, Journal of Biological Chemistry.
[103] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.
[104] R. Henry,et al. Adiponectin: more than just another fat cell hormone? , 2003, Diabetes care.
[105] W. Dietz,et al. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.
[106] Walter C Willett,et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. , 2005, The American journal of clinical nutrition.
[107] P. Pussinen,et al. Dental Infections and Cardiovascular Diseases: A Review. , 2005, Journal of periodontology.
[108] Y. Terauchi,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.
[109] J. Beck,et al. Periodontitis: a risk factor for coronary heart disease? , 1998, Annals of periodontology.
[110] Y. Kiyohara,et al. Relationship between obesity, glucose tolerance, and periodontal disease in Japanese women: the Hisayama study. , 2005, Journal of periodontal research.
[111] B. Wajchenberg. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.
[112] K. Kolodner,et al. Comparing patient and physician perception of weight status with body mass index. , 2002, The American journal of medicine.
[113] T. Pischon,et al. Association of plasma resistin levels with coronary heart disease in women. , 2005, Obesity research.
[114] Obesity: under-diagnosed and under-treated in hospital outpatient departments , 2002, International Journal of Obesity.
[115] J. Friedman,et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. , 1996, The Journal of clinical investigation.
[116] Nader Rifai,et al. Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.
[117] J. Tuomilehto,et al. Blood pressure levels in the 41 populations of the WHO MONICA Project , 1997, Journal of Human Hypertension.
[118] M. Matsuda,et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.
[119] Y. Shimazaki,et al. Obesity and periodontitis. , 1998, The New England journal of medicine.
[120] J. Gerberding,et al. Actual causes of death in the United States, 2000. , 2004, JAMA.
[121] P. Scherer,et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.
[122] M. Lazar,et al. A family of tissue-specific resistin-like molecules. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[123] Obesity in Adults,et al. Identification, Evaluation, and Treatment of Overweight and Obesity , 2021, Obesity Prevention and Treatment.
[124] A. Prentice,et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.
[125] E. Rimm,et al. Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. , 2003, Obesity research.
[126] P. Scherer,et al. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism , 2002, Trends in Endocrinology & Metabolism.
[127] S. Humphries,et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.